Cable Hill Partners, LLC Uni Qure N.V. Transaction History

Cable Hill Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$22.8 - $33.93 $11,400 - $16,965	-500 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$29.75 - $43.08 $5,950 - $8,616	200 Added 66.67%	500 $16,000
Q2 2018 Aug 03, 2018	BUY	$21.96 - $39.94 $2,196 - $3,994	100 Added 50.0%	300 $11,000
Q4 2017 Feb 22, 2018	SELL	$9.47 - $19.59 $7,576 - $15,672	-800 Reduced 80.0%	200 $4,000
Q3 2017 Oct 27, 2017	BUY	$7.7 - $9.6 $7,700 - $9,600	1,000	1,000 $10,000

154

41M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $280M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.